91 related articles for article (PubMed ID: 2204003)
1. Phase II study of pirarubicin in metastatic breast cancer.
Kleeberg UR; Reichel L; Wander HE; Beyer JH; Essers U; Fiebig HH; Salewski E; Greifenberg B; Edler L
Onkologie; 1990 Jun; 13(3):175-9. PubMed ID: 2204003
[TBL] [Abstract][Full Text] [Related]
2. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of pirarubicin in malignant pleural mesothelioma.
Kaukel E; Koschel G; Gatzemeyer U; Salewski E
Cancer; 1990 Aug; 66(4):651-4. PubMed ID: 2386894
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of pirarubicin (THP-adriamycin) in metastatic breast cancer patients.
Lenk H; Tanneberger S; Wiener N; Giesske H; Gärtner S; Geyer J; Rotte KH
Oncology; 1990; 47(2):97-100. PubMed ID: 2314831
[TBL] [Abstract][Full Text] [Related]
5. Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society.
Drings P; Günther IU; Gatzemeier U; Berdel W; Stahl M; Salewski E; Edler L
Onkologie; 1990 Jun; 13(3):180-4. PubMed ID: 2168533
[TBL] [Abstract][Full Text] [Related]
6. Phase I-II study on weekly administration of pirarubicin in patients with metastatic breast cancer.
Dittrich C; Baur M; Mader R; Schlappack O; Dudczak R; Leitha T; Lenzhofer R; Hoffmann S; Vieder L; Heberle U
Am J Clin Oncol; 1990; 13 Suppl 1():S29-39. PubMed ID: 1963274
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of tetrahydropyranyl adriamycin (pirarubicin) in elderly patients with advanced breast cancer.
Chevallier B; Mignot L; Delozier T; Morvan F; Ferme C; Herait P
Am J Clin Oncol; 1992 Oct; 15(5):395-8. PubMed ID: 1524040
[TBL] [Abstract][Full Text] [Related]
8. Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II study.
Scheithauer W; Samonigg H; Depisch D; Schüller J; Hausmaninger H; Wiegele J; Zielinsky C; Stöger H; Haider K; Preis P
Invest New Drugs; 1990 May; 8(2):207-10. PubMed ID: 2384308
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic efficacy of pirarubicin cyclophosphamide and doxifluridine in advanced and metastatic breast cancer].
Inoue K; Tabei T; Suemasu K; Higashi Y; Kurosumi M
Gan To Kagaku Ryoho; 1999 Apr; 26(5):637-42. PubMed ID: 10234294
[TBL] [Abstract][Full Text] [Related]
10. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
11. A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Stöger H; Bauernhofer T; Schmid M; Ploner F; Moser R; Derstvenscheg E; Steindorfer P; Wilders-Truschnig M; Kuss I; Samonigg H
Cancer Chemother Pharmacol; 1994; 35(2):174-8. PubMed ID: 7987997
[TBL] [Abstract][Full Text] [Related]
12. Pirarubicin in combination chemotherapy for metastatic breast cancer.
Hortobagyi GN; Theriault RL; Frye D; Walters RS; Fraschini G; Tashima CK; Ro JS; Salewski E; Buzdar AU
Am J Clin Oncol; 1990; 13 Suppl 1():S54-6. PubMed ID: 2291460
[TBL] [Abstract][Full Text] [Related]
13. 4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study.
Samonigg H; Kasparek AK; Stöger H; Schmid M; Eber B; Stark G; Weinrauch V; Pfeiffer K; Smola M; Steindorfer P
Cancer Chemother Pharmacol; 1990; 26(4):293-6. PubMed ID: 2369794
[TBL] [Abstract][Full Text] [Related]
14. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
[TBL] [Abstract][Full Text] [Related]
16. Esorubicin (4'-deoxydoxorubicin, NSC 267469) in advanced breast cancer. A phase II study of the CALGB.
Muss HB; Van Echo D; Korzun AH; Henderson IC; Campbell T; Vogelzang NJ; Rice MA; Wood W
Am J Clin Oncol; 1990 Jun; 13(3):233-7. PubMed ID: 2346128
[TBL] [Abstract][Full Text] [Related]
17. Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
Ardavanis A; Mavroudis D; Kalbakis K; Malamos N; Syrigos K; Vamvakas L; Kotsakis A; Kentepozidis N; Kouroussis C; Agelaki S; Georgoulias V;
Cancer Chemother Pharmacol; 2006 Dec; 58(6):742-8. PubMed ID: 16718470
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma.
Sridhar KS; Hussein AM; Benedetto P; Ardalan B; Savaraj N; Richman SP
Cancer; 1992 Sep; 70(6):1591-7. PubMed ID: 1516010
[TBL] [Abstract][Full Text] [Related]
19. Pirarubicin in advanced breast cancer: a French cooperative phase II study.
Spielmann M; Kerbrat P; Delozier T; Fumoleau P; Monnier A; Chevallier B; Bastit P; Namer M; Cattan A; Lucas P
Eur J Cancer; 1990; 26(7):821-3. PubMed ID: 2145903
[TBL] [Abstract][Full Text] [Related]
20. Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial.
Chia S; Clemons M; Martin LA; Rodgers A; Gelmon K; Pond GR; Panasci L
J Clin Oncol; 2006 Jun; 24(18):2773-8. PubMed ID: 16682726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
